Evidence map›Paper›PMID 23996192›Full record

ArticleCancer causes & control : CCC2013

Toenail iron, genetic determinants of iron status, and the risk of glioma.

Gabriella M Anic, Melissa H Madden, Reid C Thompson, L Burton Nabors, Jeffrey J Olson, Renato V Larocca, James E Browning, John D Brockman, Peter A Forsyth, Kathleen M Egan

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cancer causes & control : CCC, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Gabriella M AnicDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA, gabriella.anic@nih.gov.
Melissa H Madden
Reid C Thompson
L Burton Nabors
Jeffrey J Olson
Renato V Larocca
James E Browning
John D Brockman
Peter A Forsyth
Kathleen M Egan
Moffitt Cancer Center · USEmory and Henry College · USNorton Healthcare · USUniversity of Alabama at Birmingham · USUniversity of Missouri · USVanderbilt University Medical Center · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Southeast Region Case-Control Study of Adult GliomaR01CA116174 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI EGAN, KATHLEEN M. · 2007 to 2011
$4.9M
Moffitt Postdoctoral Training Program in Molecular & Genetic EpidemiologyR25CA147832 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI EGAN, KATHLEEN M. · 2010 to 2014
$2.0M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA116174NCI NIH HHS R01CA116174NCI NIH HHS R25 CA147832NCI NIH HHS R25CA147832
6 · The paper itself

Abstract

purposeIron is essential for oxygen transport and oxidative metabolism; however, elevated iron stores can trigger overproduction of reactive oxygen species and induce DNA damage. Little is known about the association between body iron stores and glioma risk. This study examined the associations of iron levels measured in toenails and genetic variants linked to body iron stores with risk of glioma in a clinic-based case-control study.

methodsSamples were collected a median of 24 days following glioma diagnosis in the cases (10th-90th percentile, range: 10-44 days). Nail iron levels were measured in 300 cases and 300 controls using neutron activation analysis. A total of 24 genetic variants associated with iron status were genotyped in 622 cases and 628 controls. Logistic regression was used to estimate odds ratios (OR) and 95 % confidence intervals (CI) for glioma risk according to toenail iron and the examined genotypes.

resultsNo association was observed between toenail iron and glioma risk when restricting to cases with nails collected within ~3 weeks of diagnosis (OR = 0.93; 95 % CI 0.46, 1.87 comparing those with high (≥14 μg/g) vs. low (<6 μg/g) iron levels). In contrast, an inverse association with increasing iron was observed after restricting to cases with a delay of 3 weeks or greater (OR = 0.42; 95 % CI 0.19, 0.95), reflecting potentially insidious effects of advancing disease on iron levels among the cases. No associations were observed for any of the examined genetic variants.

conclusionThe results do not support a role for body iron stores as a determinant of glioma risk.

Indexed as

Iron, DietaryAdolescentAdultAgedAged, 80 and overBrain NeoplasmsCase-Control StudiesDNA, NeoplasmFemaleFerritinsFollow-Up StudiesGenotypeGliomaHumansIronMaleDNA, NeoplasmFerritinsIronIron, DietaryNeoplasm Proteins

Identifiers

PMID23996192
PMCPMC3823695
OpenAlexW1978149564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.